Cameron P Simmons Selected Research

Cameron P Simmons Research Topics

Disease

41	Dengue (Dengue Fever) 12/2023 - 05/2007
23	Infections 03/2022 - 02/2002
8	Severe Dengue 12/2023 - 08/2007
8	Viremia 01/2021 - 06/2010
5	Human Influenza (Influenza) 11/2021 - 10/2006
5	Coinfection 01/2012 - 05/2005
4	Fever (Fevers) 02/2016 - 08/2010
4	Meningeal Tuberculosis (Tuberculous Meningitis) 03/2007 - 10/2003
3	Zika Virus Infection 01/2021 - 08/2016
2	Communicable Diseases (Infectious Diseases) 10/2013 - 03/2012
2	Influenza in Birds (Avian Flu) 08/2013 - 04/2009
2	Shock 02/2009 - 03/2008
1	Flavivirus Infections 01/2020
1	Vomiting 01/2017
1	Bites and Stings (Sting) 01/2016
1	Open-Angle Glaucoma (Glaucoma, Open Angle) 07/2015
1	Respiratory Tract Infections (Respiratory Tract Infection) 04/2015
1	Typhoid Fever (Typhoid) 12/2014
1	Hyperglycemia 11/2012
1	Virus Diseases (Viral Diseases) 03/2012
1	Cytokine Release Syndrome 03/2012
1	Bacterial Meningitis 11/2009
1	Convalescence 08/2008
1	Thrombocytopenia (Thrombopenia) 03/2008
1	Hydrocephalus (Hydrocephaly) 03/2007
1	Infarction (Infarctions) 03/2007
1	Tuberculosis (Tuberculoses) 10/2006
1	Disease Susceptibility (Diathesis) 10/2006
1	Inflammation (Inflammations) 07/2005
1	Leukocytosis (Pleocytosis) 07/2005

Drug/Important Bio-Agent (IBA)

13	VaccinesIBA 03/2022 - 04/2009
12	Proteins (Proteins, Gene)FDA Link 01/2020 - 07/2005
8	CytokinesIBA 03/2012 - 10/2003
7	Antiviral Agents (Antivirals)IBA 12/2023 - 08/2010
7	Immunoglobulin G (IgG)IBA 01/2021 - 03/2008
6	Immunoglobulin M (IgM)IBA 01/2021 - 05/2010
6	AntigensIBA 08/2013 - 05/2005
5	AntibodiesIBA 11/2021 - 03/2008
5	Neutralizing AntibodiesIBA 11/2019 - 08/2007
5	Dengue VaccinesIBA 11/2019 - 08/2007
4	EpitopesIBA 11/2019 - 05/2005
4	Monoclonal AntibodiesIBA 02/2015 - 05/2007
3	Viral RNAIBA 03/2011 - 10/2006
3	Dexamethasone (Maxidex)FDA LinkGeneric 11/2009 - 07/2005
2	InsecticidesIBA 12/2023 - 02/2015
2	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2021
2	Prednisolone (Predate)FDA LinkGeneric 01/2013 - 11/2012
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2013 - 11/2012
2	Peptides (Polypeptides)IBA 01/2012 - 05/2005
2	InterferonsIBA 01/2012 - 02/2009
2	EnzymesIBA 01/2012 - 01/2011
2	ChemokinesIBA 08/2008 - 07/2005
1	2-(2,4-dimethylphenyl)indan-1,3-dioneIBA 03/2022
1	Complement System Proteins (Complement)IBA 03/2022
1	ORALIT (ORS)IBA 01/2021
1	Nucleic AcidsIBA 01/2021
1	N-acetyltalosaminuronic acid (NAT)IBA 01/2021
1	Ferritins (Ferritin)IBA 01/2021
1	Carnitine (L-Carnitine)FDA LinkGeneric 01/2020
1	LipidsIBA 01/2020
1	Immunoglobulin IsotypesIBA 11/2019
1	CYD-TDV vaccineIBA 01/2018
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2017
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 02/2016
1	Lovastatin (Mevacor)FDA LinkGeneric 02/2016
1	DEET (DET)IBA 01/2016
1	Insect RepellentsIBA 01/2016
1	Immune Sera (Antisera)IBA 09/2015
1	betaglycan (TGFBR3)IBA 07/2015
1	Protein Subunits (Protein Subunit)IBA 02/2015
1	HLA-DRB1*04 antigenIBA 12/2014
1	HLA-DRB1 Chains (HLA DRB1)IBA 12/2014
1	balapiravirIBA 05/2013
1	SteroidsIBA 11/2012
1	Codon (Codons)IBA 01/2012
1	Hemagglutinins (Hemagglutinin)IBA 01/2012
1	Neuraminidase (Sialidase)IBA 01/2012
1	Glycoproteins (Glycoprotein)IBA 06/2011
1	ImmunosorbentsIBA 01/2011
1	bactericidal permeability increasing proteinIBA 12/2010
1	DefensinsIBA 12/2010
1	pancreatic elastase IIIBA 12/2010
1	Chloroquine (Aralen)FDA LinkGeneric 08/2010
1	HLA-DR Antigens (HLA-DR)IBA 06/2010
1	Immunoglobulins (Immunoglobulin)IBA 12/2009
1	Interleukin-10 (Interleukin 10)IBA 11/2009
1	InterleukinsIBA 11/2009
1	Glucose (Dextrose)FDA LinkGeneric 11/2009
1	Interleukin-8 (Interleukin 8)IBA 11/2009
1	Virulence Factors (Pathogenicity Factors)IBA 04/2009
1	DNA (Deoxyribonucleic Acid)IBA 02/2009
1	Viral ProteinsIBA 01/2009
1	HLA-A Antigens (HLA-A)IBA 08/2008
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 10/2006
1	Interleukin-6 (Interleukin 6)IBA 10/2006
1	Toll-Like Receptors (Toll-Like Receptor)IBA 10/2006

Therapy/Procedure

12	Therapeutics 08/2016 - 05/2007
2	Chemoprevention 08/2014 - 06/2014
1	Immunomodulation 03/2012
1	Aftercare (After-Treatment) 11/2009